On Tuesday, Indivior (NASDAQ: INDV) said its finance chief Ryan Preblick will step down as the British drugmaker makes changes
1 year ago
Oaktree Capital Management, the investment fund, has urged British drugmaker Indivior (NASDAQ: INDV) to cooperate with the fund in refreshing
On Thursday, Indivior (NASDAQ: INDV), the British drugmaker, cut its 2024 net revenue forecast for the second time in three
Specialty pharmaceutical company Indivior (NASDAQ: INDV) launched a $100 million share buyback on Thursday after logging a higher profit in
2 years ago
Investment fund Oaktree Capital Management has raised its stake in Indivior Plc (NASDAQ: INDV) to become its second-largest shareholder, days
Drugmaker Indivior Plc (NASDAQ: INDV) slashed its 2024 profit forecast while signaling a slowdown in sales of its top-selling opioid
